Collectively, these studies demonstrate that succinate is a critical regulator of tumor progression and angiogenesis and shed lights on SDH, HIF1α and SUCNR1 as valid targets to manipulate angiogenesis in cancer. The gene discussed is SDHB; the disease is neoplasm.